Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
*Based on manufacturer trials studying the highest doses of oral Wegovy in non-diabetics with obesity, or with overweight plus a weight-related medical condition, when paired with diet and exercise changes (vs ~2% with diet and exercise alone)
Written by Dr Emil Gadimali MBBS MBA BMI Calculator *If you have an Asian, Chinese, Middle Eastern, Black African or African-Caribbean family background: 23 to 27.4 overweight 27.5 or above obese
This makes it a promising option for medical aestheticians and patients seeking long-term, science-backed solutions for longevity and skin health
Novo Nordisk, FDA approves once-weekly Wegovy injection for the treatment of obesity in teens aged 12 years and older (2022)
US$ 28.24
US$ 29.50
US$ 28.72
